Analysis of the Global Respiratory Distress Syndrome Market
The most common respiratory disorder in preterm infants is respiratory distress syndrome, also known as hyaline membrane disease. Inadequate pulmonary surfactant is the primary cause of respiratory distress syndrome. Shortness of breath, nasal flaring, and grunting are all symptoms of respiratory distress syndrome. RDS appears immediately or within 4 hours of birth. Antenatal glucocorticoids, continuous positive air pressure (CPAP), positive end expiratory pressure, and surfactant replacement therapy can all be used to treat respiratory distress syndrome. According to the UCSF Medical Centre, RDS affects 40,000 infants in the United States each year and accounts for approximately 20% of neonatal deaths. Market Scope The respiratory distress syndrome market is divided into product, route of administration, drug type, age, and end user segments. The growth among segments allows you to analyses niche pockets of growth and market approaches, as well as determine your core applica...